<i>miR-146a</i> LNA treatment inhibits OSCC oncogenicity. by Pei-Shi Hung (489732)

“…Rt, quantification of the weight of resected tumors. Data shown are the means ± SE from at least triplicate analysis or five mice. …”

Summary of the framework for the computation of the brain transition cost from EEG data. by Giacomo Barzon (19832364)

Characterization of microglial cell activation. by Shirley D. Wenker (17048367)

Effects of GLSF on UV induced suppression of CHS in mice. by Ayaz Shahid (12269599)

Acute toxicity assessment. by Shen Huang (9967526)

RICTOR silencing inhibits cell proliferation via UGCG regulation. by Mohammad Nafees Ansari (22232505)

“…(<b>F</b>) Fold change (mean ± SEM, <i>n</i> = 5) in different sphingolipid species reveals an increase in ceramides and a decrease in glucosylceramides in MCF-7_RICTOR^SH cells compared to MCF-7 cells. …”

Mechanical Behavior of a Novel Nanocomposite Polysulphone - Carbon Nanotubes Membrane for Water Treatment by Wang, Kui

“…Uniaxial tensile behavior of the membranes was characterized by means of a universal material testing machine under different testing conditions. …”
Get full text
Get full text

Probability of colonization of microbial taxon 1 as a function of its frequency in the pool of colonizers. by Román Zapién-Campos (9592478)

Effect of desilication temperature on hybrid desilication by Nian Liu (29935)

Effect of ATM inhibitors on the reduction of opacity. by Masaya Nagaya (13851123)

Effects of GLSF and GLS gastrointestinal juice extracts on cell viability and transformation in JB6 P+ cell line. by Ayaz Shahid (12269599)

Cilostazol inhibits endothelin-induced calcium increase and vasoconstriction in mouse intracranial arteries. a. by Yoshifumi Kawanabe (308848)

“…Arrows denote basilar artery constriction. Bar = 50 µm <b>c.</b> Cilostazol significantly decreases endothelin-induced cytosolic calcium increase. …”

Different defense-disease relations illustrated by a ‘see-saw but see-see’ model. by Alexander Kröner (346297)

The in vitro and in vivo effect of a chemokine inhibitor CTCE-9908 in combination with Kynurenine metabolites on tumour adhesion by Danielle Tatchum (16946574)

“…In the non-cancerous cell lines HaCaT and EA. hy926, there was a decrease in percentage cell number after treatment with L-kyn, phorbol 12-myristate 13-acetate (PMA), a positive control for adhesion, and CTCE-9908, suggesting a decrease in cell adhesion in the non-cancerous cell lines.…”

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis by Steffie K. Naber (2175986)

“…</p><p>Methods</p><p>We used the MISCAN-Cervix model to determine the optimal screening strategy for a pre-vaccination population and for vaccinated women (~80% decreased risk), assuming a willingness-to-pay of €50,000 per quality-adjusted life year gained. …”

Joey Tan: The role of preptin in the response of bone tissue to a high-fat diet by Joey Tan (11499238)

ILEI expression in melanoma. by Ken Noguchi (255943)

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”